Cargando…
Evidence-based endoscopic management of Barrett’s esophagus
Barrett’s esophagus (BE) develops as a consequence of chronic esophageal acid exposure, and is the major risk factor for esophageal adenocarcinoma (EAC). The practices of endoscopic screening for—and surveillance of—BE, while widespread, have failed to reduce the incidence of EAC. The majority of EA...
Autores principales: | Yachimski, Patrick, Hur, Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324864/ https://www.ncbi.nlm.nih.gov/pubmed/25237038 http://dx.doi.org/10.1093/gastro/gou059 |
Ejemplares similares
-
Patient decision-making and clinical outcomes following endoscopic therapy or esophagectomy for Barrett’s neoplasia
por: Lockwood, Robert, et al.
Publicado: (2017) -
Endoscopic mucosal resection or ablation for Barrett’s esophagus
containing high grade dysplasia: agreement strongest among expert
gastroenterologists
por: Canipe, Ashley, et al.
Publicado: (2014) -
The evolution of endoscopic therapy for Barrett’s
esophagus
por: Condon, Ashwinee, et al.
Publicado: (2021) -
Barrett Esophagus: When to Endoscope
por: Butt, Joshua, et al.
Publicado: (2014) -
Optimal management of Barrett’s esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda, Vani JA, et al.
Publicado: (2011)